Laden $YTEN expecting positive news when the company details its work with its C3004 trait in the coming weeks. Given the potential for significant royalty/license payments in future years, we are maintaining our Buy rating and 12-month $7.00 price.
Laden $YTEN expecting positive news when the company details its work with its C3004 trait in the coming weeks. Given the potential for significant royalty/license payments in future years, we are maintaining our Buy rating and 12-month $7.00 price.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.